Title |
Radiotherapy for Non-Hodgkin’s lymphoma: still standard practice and not an outdated treatment option
|
---|---|
Published in |
Radiation Oncology, August 2016
|
DOI | 10.1186/s13014-016-0690-y |
Pubmed ID | |
Authors |
Michel Zimmermann, Christoph Oehler, Ulrich Mey, Pirus Ghadjar, Daniel Rudolf Zwahlen |
Abstract |
Two large, recently published observational studies demonstate a clear down-trend in the use of radiotherapy (RT) over the last 15 years, both in the setting of follicular and diffuse large B-cell lymphoma. This change of practice might have a negative impact on clinical outcome. Even within the context of modern systemic therapy, omission of RT translates not only into a shorter progression-free survival (PFS), but also into a worse overall survival (OS). RT should therefore remain standard practice.This short review is aiming to summarize current guidelines and the best evidence available in the management of non-Hodgkin's lymphoma. Potentially practice changing, ongoing trials will be highlighted. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Algeria | 1 | 33% |
United Kingdom | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 67% |
Members of the public | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Unknown | 70 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 18% |
Student > Master | 12 | 17% |
Researcher | 10 | 14% |
Other | 7 | 10% |
Student > Ph. D. Student | 5 | 7% |
Other | 9 | 13% |
Unknown | 15 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 31 | 44% |
Nursing and Health Professions | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 4 | 6% |
Agricultural and Biological Sciences | 3 | 4% |
Psychology | 2 | 3% |
Other | 8 | 11% |
Unknown | 18 | 25% |